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We have initiated studies on the mechanism of early transcriptional activation of the early he65 promoter during infection
with Autographa californica multicapsid nuclear polyhedrosis virus. This analysis is based on a comparison of the sequences
required for he65 promoter activation with those sequences that support specific protein binding. The he65 promoter is
located immediately downstream of the homologous region (hr) 4a. The sequences of hr4a are characterized by two
imperfect palindromes of 24 bp. The results of transient expression assays indicate promoter activation in the presence of
both the proximal palindrome and the known viral trans-regulator IE1. The results of mobility shift assays and DNaseI
footprinting analyses reveal differences in specific protein binding at and close to the proximal palindrome depending on
whether the nuclear protein extracts are prepared from uninfected or infected cells. The analysis of the protein binding
complex at the proximal inverted repeat with extracts from infected cells suggests the involvement of both IE1 and IE0 as
oligomers. The minimal protein binding sequences include the left half-site of the 24 bp repeat with 9 additional bp of the
flanking sequences. The right half-site of the repeat also directs binding although with lower affinity as confirmed by
phenanthroline-copper footprinting assays. Both half-sites of the repeat are thus essential for he65 promoter activation,
suggesting that IE1 acts via cooperative binding. We conclude that the proximal inverted repeat is able to interact with both
IE1 and IE0 although IE1 is sufficient for activation at least in transient expression assays. © 1998 Academic Press
INTRODUCTION
Gene expression of the baculovirus Autographa cali-
fornica multicapsid nuclear polyhedrosis virus (AcMNPV)
can be divided into early, late and very late phases.
Transcription of late and very late genes is mediated by
a virus-induced RNA polymerase, while early promoters
are recognized by the host RNA polymerase II (for re-
views see O’Reilly et al., 1994; Blissard, 1996). As dem-
onstrated by transient expression assays, the transcrip-
tional activity of some early promoters depends exclu-
sively on host factors while others need additional viral
activators. To date, only two host proteins have been
described that may be involved in the regulation of early
viral transcription (Krappa et al., 1992; Kogan and Blis-
sard, 1994). The best-studied viral transcription factor is
IE1, which is highly conserved among baculoviruses and
which is thought to act as a multifunctional protein dur-
ing the infection cycle. As initially shown for the 39K and
p35 promoters, IE1 can function as transcriptional acti-
vator of early promoters (Guarino and Summers, 1986b;
Nissen and Friesen, 1989). Infection studies with cyclo-
heximide as inhibitor of protein synthesis further support
the view that IE1 modulates early gene transcription
during the infection cycle (Ross and Guarino, 1997). In
addition to the stimulatory effect of IE1, cotransfection
studies demonstrate the potential of IE1 to regulate neg-
atively the early promoters ie2 and pe38 (Kovacs et al.,
1991; Leisy et al., 1997). Moreover, IE1 may be involved
directly or indirectly in viral replication and late transcrip-
tion (Passarelli and Miller, 1993; Lu and Miller, 1995).
Infection with a temperature-sensitive mutant that car-
ries a mutated ie1 gene leads to a delay of viral replica-
tion (Ribeiro et al., 1994). This finding suggests a func-
tional role of IE1 during infection.
There is evidence that IE1 acts both by sequence-
independent (Blissard and Rohrmann, 1991; Blissard et
al., 1992) and by sequence-dependent mechanisms
(Guarino and Summers, 1986a). The sequence-depen-
dent activation relies on the presence of sequences from
homologous regions (hrs), which are interspersed
throughout the AcMNPV genome at eight different loca-
tions (Cochran and Faulkner, 1983; Ayres et al., 1994).
These eight hrs (hr1, hr1a, hr2, hr3, hr4a, hr4b, hr4c, and
hr5) are characterized by two to eight copies of imperfect
palindromes each containing an EcoRI site at its center
(Guarino et al., 1986). As mainly shown for hr5, the
cis-linkage of hrs to early promoters leads to enhanced
expression in the presence of IE1 (Guarino and Sum-
mers, 1986a; Guarino et al., 1986; Nissen and Friesen,
1989). The hrs may also act as origins of DNA replication
(for review see Kool et al., 1995).
The only known spliced gene of AcMNPV is ie0,
whose ORF is identical to the ie1 ORF with 54 additional
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amino acids at the N terminus (Chisholm and Henner,
1988). Little is known about the role of IE0 as a trans-
regulator (Kovacs et al., 1991).
Our interest is focused on how early viral promoters
are regulated by host factors in concert with viral gene
products during the infection cycle. We have analyzed
the early he65 promoter since the close proximity to hr4a
(formerly hr4left), and the transcriptional delay in compar-
ison with the major early genes ie1, ie2, me53, and pe38
has suggested a potential role of IE1 in the activation
process in vivo (Becker and Knebel-Mo¨rsdorf, 1993). Our
recent results demonstrate that indeed IE1 can activate
the he65 promoter in insect TN-368 and mammalian
BHK21 cells (Murges et al., 1997). Here, we present the
analysis of the he65 promoter sequences that are es-
sential both for the activation by IE1 and for the binding
of specific protein complexes that contain IE1 or IE1 and
IE0. Thus our results provide the first evidence for the
putative role of IE1 and IE0 in the regulation of the he65
promoter.
RESULTS
Experimental design
The regulation of the early he65 promoter was ana-
lyzed in the permissive cell lines S. frugiperda and TN-
368. By transient expression and DNA–protein interac-
tion studies, we have investigated the role of IE1 in the
activation process. Various deletions in the he65 pro-
moter were tested for activity to determine the se-
quences sufficient for transcriptional activation upon co-
transfection with IE1-expressing plasmids. The DNA–
protein complex formed at the activating sequences and
the involvement of IE1 were studied by mobility shift
assays and footprinting analyses.
Activation of the he65 promoter in AcMNPV-infected
S. frugiperda and TN-368 cells
We cloned he65 promoter fragments in front of the
reporter gene CAT (Fig. 1b) and tested the activity of
these constructs in uninfected or AcMNPV-infected S.
frugiperda and TN-368 cells, respectively. All promoter
constructs include the transcriptional and translational
start sites of the he65 gene but vary in the lengths of their
upstream sequences (Fig. 1b). Plasmid pHE65-CAT474
contains the complete hr4a, whereas pHE65-CAT220
carries the proximal of the two inverted repeats present
in hr4a (Fig. 1b). Plasmid pHE65-CAT184 lacks one-half
of the proximal 24-bp inverted repeat (Fig. 1b). After
transfection of these he65 promoter constructs, no activ-
ity was observed in uninfected S. frugiperda or in unin-
fected TN-368 cells (Fig. 2), indicating that viral factors
were needed for the activation of the he65 promoter.
When S. frugiperda cells were infected with AcMNPV
prior to transfection, the constructs pHE65-CAT474 and
pHE65-CAT220 were activated while no significant CAT
expression over basal levels was observed from the
shorter construct pHE65-CAT184 (Fig. 2). In three inde-
pendent experiments, pHE65-CAT220 was about three-
fold less active than pHE65-CAT474. In infected TN-368
cells, only pHE65-CAT474 was efficiently expressed (Fig.
2), although some experiments also indicated a slight
activation of pHE65-CAT220 (data not shown). These
results imply that the complete hr4a supports transcrip-
tional activation by viral factors, whereas promoter con-
structs without hr4a (pHE65-CAT184) are not activated.
The presence of the complete proximal inverted repeat
(pHE65-CAT220) led to increased CAT expression in in-
fected S. frugiperda cells but was barely detectable in
infected TN-368 cells.
Transfection experiments in TN-368 cells demonstrate
that in contrast to pHE65-CAT184, pHE65-CAT220 is ac-
tivated by coexpression of IE1 (Murges et al., 1997). In
the present study, we have demonstrated the activation
of pHE65-CAT220 and pHE65-CAT474 in S. frugiperda
and TN-368 cells after cotransfection with IE1-express-
ing plasmids (Fig. 2, lanes 1). The higher expression
level in TN-368 cells was probably due to a higher
transfection efficiency in comparison with S. frugiperda
cells. The observation that both constructs (pHE65-
CAT220 and pHE65-CAT474) were active in cotrans-
fected TN-368 cells was in contrast to the reduced ac-
tivity of pHE65-CAT220 in infected TN-368 cells. Differ-
ences in the amount of IE1 in transfected versus infected
cells might account for this apparent discrepancy. How-
ever, the proximal inverted repeat might be sufficient for
activation when only IE1 is present. Additional factors
present in infected cells might interfere with the action of
IE1. This putative interference would be compensated by
the presence of the complete hr4a. The involvement of
additional factors during AcMNPV infection is supported
by the finding that the time course of he65 transcription
differs in TN-368 and S. frugiperda cells (data not shown)
although the level of IE1 expression is comparable (Ron-
carati and Knebel-Mo¨rsdorf, 1997; see Fig. 10b).
Protein binding to the he65 promoter in nuclear
extracts from uninfected and infected cells
Since activation of the he65 promoter was dependent
on viral factors, we investigated whether a difference in
factor binding was detectable when nuclear extracts
from uninfected or infected cells were used. In vitro
DNaseI footprinting of the 474-bp XhoII/StyI fragment,
representing the coding strand (Fig. 3c), was performed
with crude nuclear extracts from uninfected or infected (4 h
p.i.) S. frugiperda cells. With poly(dI-dC) as nonspecific
competitor, four major protected regions were visible in
the presence of nuclear extracts from either uninfected
or infected cells (Fig. 3a, gray boxes). The protected
regions are flanking each of the two inverted repeats in
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the hr4a sequences (Fig. 3c). Further protected se-
quences were detectable in extracts both from unin-
fected and infected cells with poly(dG-dC) as nonspecific
competitor (Fig. 3b, gray box). These sequences are
located at the proximal inverted repeat between nucleo-
tides 2140 to 2137 relative to the transcriptional start
site (Fig. 3c). With poly(dA-dT), reproducible data were
not obtained (data not shown).
Although no striking differences in factor binding were
observed (Figs. 3a and 3b, gray boxes), minor changes
were visible in the presence of poly(dI-dC) (Fig. 3a, filled
and open boxes). Hypersensitive sites were detectable
downstream of the protected region II and upstream of
the proximal inverted repeat in extracts from infected
cells but not in extracts from uninfected cells (Fig. 3a,
filled box). These sites are located between nucleotides
2170 and 2150 relative to the transcriptional start site
(Figs. 3a and 3c). Furthermore, weak protection was
FIG. 1. The he65 promoter. (a) Location of the he65 gene on the AcMNPV genome. The linearized EcoRI map of the AcMNPV plaque isolate E
genome is shown. The eight homologous regions (hr) are indicated, and the black arrow represents the he65 open reading frame. (b) Schematic
representation of the he65 promoter constructs. Thick lines indicate the lengths of the promoter fragments, and the transcription initiation site is
indicated by bent arrows. The numbers refer to the nucleotides relative to the transcription initiation site. The gray box indicates sequences of hr4a.
The sequences of the proximal 24-bp inverted repeat are boxed, and the repeats are indicated by arrows. Restriction site abbreviations: E, EcoRI; C,
ClaI. The he65 promoter constructs were named as follows: construct pHE65CAT-IRprox contains the proximal inverted repeat with 26 bp of the
flanking sequences; pHE65CAT-IR, and pHE65CAT-IRS carry a deletion in the flanking sequences of 17 and 25 bp, respectively; only the left half-site
of the inverted repeat, and 8 bp of the upstream flanking sequences as compared with IRS are present in pHE65CAT-IRL/UF8 and pHE65CAT-IRL/
UF8s. The broken line at IRL-UF8 indicates the deletion of the right half-site, and the broken line at IRL-UF8s depicts the substitution by unrelated
sequences. The hr4a/he65 promoter sequences in pHE65CAT-IRprox are identical to those in constructs pHE65-CAT220 and pHE65CAT-220P, and
the promoter sequences of pHE65CAT-IRR/DF are identical to those in pHE65-CAT184.
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observed in extracts from infected cells at nucleotides
2140 to 2130 (Fig. 3a, open box). These protected se-
quences overlapped with the 4 nt protected in extracts
both from uninfected and infected cells when poly(dG-
dC) was used as nonspecific competitor (Fig. 3b, for
summary, see 3c). This finding suggests that the left
half-site of the proximal repeat can interact with cellular
factors that might compete for binding when viral factors
are present. We conclude from the results of the DNaseI
footprinting assays that differences in factor binding are
restricted to sequences of the proximal inverted repeat
and the upstream flanking region.
Specific protein binding to sequences at and close to
the proximal inverted repeat in nuclear extracts from
infected cells
We performed mobility shift experiments to investigate
the potential difference in specific DNA–protein binding
at the proximal inverted repeat and its flanking se-
quences in extracts from uninfected and infected cells.
The oligonucleotide IRprox, which was used as probe,
corresponds to the upstream promoter sequences in
pHE65-CAT220 (Fig. 5). This DNA probe contains both
the sequences for specific binding in protein extracts
prepared from infected S. frugiperda cells and the se-
quences that were sufficient to support promoter acti-
vation.
After incubation of the probe IRprox with nuclear ex-
tracts from S. frugiperda cells prepared at 4 h p.i., a
tripartite DNA–protein complex was visible with poly(dA-
dT) and poly(dI-dC) as nonspecific competitors (Fig. 4,
arrowhead). This complex was not detectable with ex-
tracts from uninfected cells (Fig. 4). The specificity of the
DNA–protein complex was demonstrated by competition
with an excess of unlabeled IRprox, whereas the unre-
lated oligonucleotide FX did not interfere with protein
binding (Fig. 4). The observation that IRprox forms com-
plexes with factors from either uninfected or infected
cells is in line with our results of the DNaseI footprinting
assays.
We have concentrated on studies of the protein com-
plex formed in infected cells. Competition experiments
were performed with oligonucleotides containing differ-
ent deletions in the upstream promoter sequences to
identify the stretch of sequences that was responsible
for the specific protein binding (Fig. 5). In extracts from
infected cells, binding to the IRprox probe was competed
for by oligonucleotide IR containing a deletion of 16 bp
(Fig. 5 and Fig. 6a, lane 3). However, almost no compe-
tition was observed for IRS, which is 8 bp shorter than IR
(Fig. 5 and Fig. 6a, lane 6). When IR was used as the
probe, binding was comparable with IRprox, whereas
only a slightly shifted complex was detectable with the
IRS probe (data not shown). These results indicate that a
stretch of 9 bp located upstream of the proximal 24-bp
inverted repeat is involved in specific complex formation.
The oligonucleotide UF was used as the probe to
investigate whether the upstream flanking sequences of
the inverted repeat were sufficient for protein binding
(Fig. 5). Since no binding was observed (Fig. 6c, lane 6),
we investigated binding to oligonucleotides that con-
tained the left half-site of the inverted repeat in addition
to the upstream flanking sequences of different lengths
(Fig. 5). Oligonucleotides IRL-UF, IRL-UF16, and IRL-UF8
(Fig. 5) supported binding of a protein complex (Fig. 6c,
lanes 5, 2, and 3) that could be competed for by the
FIG. 2. CAT activity of he65 promoter constructs in S. frugiperda and TN-368 cells. The constructs pHE65-CAT474, pHE65-CAT220, and
pHE65-CAT184 were transfected into uninfected (lanes 2) or infected cells (lanes i) or cotransfected with the IE1-expressing plasmid pIE1 (lanes 1).
The percentage of acetylated CAM is given underneath the autoradiogram.
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FIG. 3. In vitro DNaseI footprinting of the he65 promoter with nuclear extracts from uninfected or infected (4 h p.i.) S. frugiperda cells. (a) The coding
strand was labeled by 39-end-filling of the StyI site. The labeled DNA was incubated with crude nuclear extracts from uninfected cells (lanes un) or
from cells prepared at 4 h p.i. (lanes 4). The control reaction containing naked DNA (lanes no) was digested with 10 ng (lane 10), 5 ng (lanes 5), or
2.5 ng (lane 2.5) of DNaseI. For the DNA incubated with extracts, 100 ng (lanes 100), 40 ng (lanes 40), or 20 ng (lane 20) of DNaseI were used. Each
reaction mixture contained 5 mg of poly(dI-dC) as nonspecific competitor. DNA size markers (lane M), and a sequencing ladder (lanes A, T, C, and
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oligonucleotides IRprox and IR (data not shown) and vice
versa (Fig. 6a, lanes 4 and 7). Oligonucleotide IRL con-
taining only the left half-site of the inverted repeat (Fig. 5)
showed neither protein binding (Fig. 6c, lane 4) nor
competition for the complex formed at IRprox (Fig. 6a,
lane 8). Since IRL might be too short for stable complex
formation, we also used the oligonucleotide IRLs with 8
supplemented nt that were unrelated to hr4a (Fig. 5). The
observation that IRLs served as a weak competitor and
the oligonucleotide of the same length, IRL-UF8, com-
peted efficiently (Fig. 6a, lanes 11 and 7) led us to the
conclusion that both the sequences of the inverted re-
peat and the 9 bp of the flanking region had to be
involved in binding.
Binding and competition studies with the oligonucle-
otide IRL-UF8s, in which the right half-site of the inverted
repeat was replaced by unrelated sequences (Fig. 5),
demonstrated no difference in complex formation as
compared to IR (Fig. 6a, lanes 5 and 3). We used oligo-
nucleotides containing only the right half-site of the in-
verted repeat (IRR) or the right part with the downstream
flanking sequences (IRR-DF) (Fig. 5) for competition stud-
ies to investigate whether the right half-site of the repeat
indeed was not involved in specific binding. IRR could
not compete for the complex formed at IRprox, whereas
IRR-DF served as weak competitor (Fig. 6a, lanes 9 and
10), suggesting that binding occurred with low affinity at
the right half-site of the repeat only in the presence of the
downstream flanking sequences.
In summary, the mobility shift assays demonstrate that
a specific tripartite complex is formed in extracts from
infected cells at the left half-site of the proximal inverted
repeat and at least 9 nt of the upstream flanking se-
quences. The right half-site with the downstream flank-
ing sequences competes for the tripartite complex with
low affinity.
Since the presence of the proximal inverted repeat
was sufficient for activation of the he65 promoter by IE1,
we have analyzed whether the same sequences that
interact with factors from infected cells also interact with
factors from cells transfected with IE1-expressing plas-
mids. Competition experiments were performed in nu-
clear extracts from TN-368 cells transfected with IE1-
expressing plasmids and with IRprox as the probe. Oli-
gonucleotides that competed for binding in extracts from
infected cells also competed for the complex formed in
extracts from transfected cells (Fig. 6b). Only IRLs that
competed weakly for binding in extracts from infected
cells showed stronger competition in extracts from trans-
fected cells (Figs. 6a, lane 11, and 6b, lane 11). Thus we
conclude that the same sequences are involved in bind-
ing when extracts from infected and transfected cells
have been used.
Activation of the minimal he65 promoter by
coexpression of IE1
We have tested he65 promoter constructs for activity
after coexpression of IE1 to address the question of
whether sequences that support the specific binding
complex observed either in extracts from infected and
transfected cells correlate with those sequences that are
essential for the activation by IE1. The 59 ends of the
he65 promoter constructs corresponded to the se-
quences of the oligonucleotides that were used for the
binding studies. Transient expression assays were per-
G) are shown. The positions of the DNA fragments are indicated on the left. Gray boxes indicate protected regions with extracts from both uninfected
and infected cells. The filled and the open boxes indicate hypersensitive and protected nucleotides, respectively, with extracts from infected cells.
(b) Poly(dG-dC) was used as nonspecific competitor. (c) Nucleotide sequence of the he65 promoter. The numbers refer to the nucleotides relative to
the he65 transcriptional start sites that are depicted by arrows. The protected regions are shaded, the hypersensitive sites are overlined, and the
protected region with extracts from infected cells is indicated by a broken line. The two inverted repeats of hr4a are boxed.
FIG. 4. Specific protein binding at the proximal inverted repeat of
hr4a. Mobility shift assays with nuclear extracts from uninfected (lanes
un) or infected S. frugiperda cells prepared at 4 h p.i. (lanes 4) were
performed with poly(dA-dT), poly(dG-dC), or poly(dI-dC) as nonspecific
competitors. The 39-end labeled oligonucleotide IRprox was competed
for by 5, 50, and 125 ng of unlabeled IRprox competitor and by 125 ng
of the unrelated competitor FX. Lanes 2, no further competitor added.
The position of the tripartite complex and of the probe are marked by
an arrowhead and by an asterisk, respectively.
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formed in TN-368 cells which showed a higher expres-
sion level of the transfected plasmids as compared to S.
frugiperda cells.
After cotransfection of the IE1-expressing plasmid
pIE1, the pHE65CAT-IR construct (Fig. 1b) was as effi-
ciently activated as pHE65-CAT220 (Fig. 7). CAT expres-
sion of pHE65CAT-IRS containing only the inverted re-
peat without upstream flanking sequences (Fig. 1b) was
significantly reduced (Fig. 7) as observed in four inde-
pendent experiments. Activation by IE1 was observed
neither for pHE65CAT-IRL/UF8 nor for pHE65CAT-IRL/
UF8s (Fig. 7), which both contain only the left half-site of
the inverted repeat (Fig. 1b). The construct pHE65CAT-
IRL/UF8 carries a deletion of the right half-site which was
substituted by unrelated sequences in pHE65CAT-IRL/
UF8s (Fig. 1b). Thus the he65 promoter requires a com-
plete copy of the proximal inverted repeat with at least 9
bp of the flanking sequences for the activation by IE1. By
replacing the right half-site of the repeat by unrelated
sequences, we could demonstrate that sequence spec-
ificity rather than spacing of promoter sequences were
essential for activation. The deletion of 8 bp of the up-
stream flanking sequences resulted in reduced promoter
activation. These sequences were also required for the
formation of the specific protein complex in extracts from
infected and transfected cells (Fig. 5). Thus weak expres-
sion of pHE65CAT-IRS correlates with the reduced pro-
tein binding at IRS (Fig. 5). We argue that in the case of
IRS, weak binding occurs at the left half-site of the repeat
and is stabilized by the interaction with downstream
sequences. Weak promoter activity ensues. When the 8
bp of the upstream flanking sequences are present,
binding and activation are more efficiently accomplished.
As control, we performed transfection experiments
which demonstrate the compatibility of various promoter
constructs. Activation by IE1 was shown for pHE65CAT-
IRprox and pHE65-CAT220P (Fig. 7), which both contain
the same he65 promoter sequences as pHE65-CAT220
but differ in the cloning sites of the promoter fragment
(see Fig. 1b). Accordingly, pHE65-CAT184 corresponds to
pHE65CAT-IRR/DF, which carries the promoter fragment
in the same sites of pBLCAT3 as pHE65CAT-IRL/UF8s,
-IRL/UF8, -IRS, -IR, and -IRprox (see Fig. 1b).
The role of IE1 in the binding complex
at the inverted repeat
We performed mobility shift experiments using IRprox
as probe with nuclear extracts from infected S. frugi-
perda cells, infected TN-368 cells, or from TN-368 cells
transfected with IE1-expressing plasmids to compare the
complexes formed in each extract. The tripartite complex
formed in extracts from either infected TN-368 or S.
frugiperda cells migrated at the same position (Fig. 8,
lanes 1 and 13, shown by a filled arrowhead) and could
be competed for by the same specific oligonucleotides
(data not shown). The complex formed in extracts from
transfected cells (Fig. 8, lanes 5 and 9) migrated differ-
ently than that from infected cells (lanes 1 and 13). The
tripartite complex (Fig. 8, filled arrowhead) was replaced
by one major complex (Fig. 8, open arrowhead) that
migrated at the same position as the fastest migrating
band of the tripartite complex.
FIG. 5. Schematic representation of the oligonucleotides used for mobility shift assays. The sequences from 2106 to 2165 relative to the he65
transcription initiation start are shown. The proximal inverted repeat is boxed and the repeats are indicated by arrows with an EcoRI (E) site at its
center. The black bars represent the he65 sequences of the oligonucleotides; broken lines indicate unrelated sequences. Complex formation and
competition of each oligonucleotide are indicated by 11, weak complex formation and competition by 1a, weak competition and nearly no complex
formation by (1)b, and neither complex formation nor competition by 2.
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Since IE1 activated the he65 promoter, we analyzed
whether IE1 was involved in the binding complex. The
complexes formed in extracts from either infected or
transfected cells were incubated with polyclonal IE1 an-
tiserum which led to a supershift of the retarded bands
(Fig. 8, lanes 2, 6, 10, and 14). These results confirm that
IE1 was at least part of both the tripartite binding com-
plex (Fig. 8, lanes 2 and 14) and the complex formed in
extracts from transfected cells (Fig. 8, lanes 6 and 10). As
control, preimmune and anti-IE2 sera were used which
did not affect complex migration (Fig.7, lanes 3, 4, 7, 8, 11,
12, 15, and 16).
We performed protein clipping bandshift assays
(Schreiber et al., 1988; Schoeler et al., 1989) to investi-
gate whether the tripartite complex formed in extracts
from infected cells results from binding of different pro-
teins. This method is based on the limited proteolytic
cleavage of the preformed DNA–protein complex by add-
ing specific proteases. After electrophoresis, the result-
ing pattern of retarded bands represents the binding
peptide(s). Hence this method allows determination of
whether one or more peptides have been bound to DNA.
The diluted protease chymotrypsin was added to the
DNA–protein complex that had formed in extracts from
infected cells. The resulting complexes were analyzed by
electrophoresis, which demonstrated that the tripartite
complex was replaced by one faster migrating band (Fig.
9). Similar results were obtained after adding increasing
amounts of the protease dispase (Fig. 9). These results
suggest that one peptide binds to DNA and raise the
question of whether the tripartite complex reflects bind-
ing of a protein that forms oligomers. We investigated
whether the formation of the DNA–protein complex was
based on protein–protein interactions by adding the dis-
sociating agent deoxycholate (DOC) to the preformed
DNA–protein complex. When DOC was added in low
concentrations, binding was inhibited without generating
faster migrating complexes (Fig. 9). The inhibition of
binding could be restored by adding an excess of the
nonionic detergent NP-40 (Fig. 9). Thus the DOC exper-
iments suggest that only dimers or oligomers support
DNA binding.
Expression of the ie1 and ie0 genes after transfection
and during the course of infection
The expression of the IE1 gene is observed throughout
the course of infection, whereas IE0 is only expressed
during the early phase (Ohresser et al., 1994; Choi and
Guarino, 1995a). Recent studies provide evidence that
distinct domains of IE1 are responsible for DNA binding,
transactivation, or negative regulation (Kovacs et al.,
1992; Rodems et al., 1997; Slack and Blissard, 1997).
Since IE1 and IE0 are identical in their C terminus, both
contain the same DNA binding domain. Thus the nuclear
extracts which we prepared from cells at 4 h p.i. might
provide IE1 and IE0, which potentially can bind to the
same sequences. In contrast, in cells transfected with
pIE1, only IE1 is expressed. We performed transient ex-
pression assays with the plasmids pIE1 and pHindG to
investigate whether the presence or absence of IE0 may
account for the differences in the shifted complex formed
in extracts from infected and transfected cells. Construct
pHindG contains the fragment HindG of the AcMNPV
genome potentially encoding both IE1 and IE0 (Kovacs et
al., 1991; Ohresser et al., 1994). Interestingly, no differ-
ence in binding was observed when extracts were used
from cells transfected with either pIE1 or pHindG (Fig. 8).
We compared IE1 and IE0 expression by Western blot
FIG. 6. The minimal sequences forming the specific protein complex
in nuclear extracts from S. frugiperda cells prepared at 4 h p.i. and
TN-368 cells transfected with IE1-expressing plasmids. (a) Mobility
shift assays were performed in extracts from infected cells prepared at
4 h p.i. with poly(dA-dT) as nonspecific competitor and oligonucleotide
IRprox as probe [lanes 4 (AT)]. As competitors, 100 ng of each of the
oligonucleotides IRprox, IR, IRL-UF16, IRL-UF8s, IRS, IRL-UF8, IRL,
IRR-DF, IRR, and IRLs were used. (b) The same competition experiment
as described under (a) was performed with nuclear extracts from
TN-368 cells transfected with IE1-expressing plasmids [lanes IE1 (AT)].
(c) Shift assays were performed in extracts from infected cells prepared
at 4 h p.i. with poly(dA-dT) as nonspecific competitor and oligonucle-
otides IRprox, IRL-UF16, IRL-UF8, IRL, IRL-UF, and UF as probes. The
positions of the probes are marked by asterisks; the position of the
tripartite complex (a) and of the specific complex formed in transfected
cells (b) are indicated by arrowheads. Each lane is numbered.
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analyses in nuclear extracts prepared from infected cells
with extracts from cells transfected with either of the
plasmids pIE1 or pHindG to confirm whether indeed both
proteins were expressed. In extracts prepared at 4 h p.i.,
two polypeptides were detectable with the IE1 antiserum
directed against a common N-terminal domain of IE1 and
IE0 (Fig. 10c). The predicted molecular weights of IE0
and IE1 are 73 and 67 kDa, respectively (Chisholm and
Henner, 1988). Thus the polypeptides of approximately
82 and 76 kDa may reflect IE0 and IE1 expression,
respectively (Figs. 10b and 10c). The IE1-specific
polypeptide was also observed in extracts from cells
transfected with pIE1, although no expression of IE0 was
detectable in extracts from cells transfected with pHindG
(Fig. 10c). This finding may explain why DNA binding did
not differ in extracts from cells transfected with either
pIE1 or pHindG (Fig. 8). The presence of IE1 and IE0 in
FIG. 7. CAT activity of he65 promoter constructs in TN-368 cells after cotransfection with IE1-expressing plasmids. Each of the promoter constructs
was transfected into uninfected cells (lanes 2) or cells transfected with IE1-expressing plasmids (lanes 1). The relative CAT activity is shown below
the autoradiogram.
FIG. 8. IE1 is part of the specific complex formed in nuclear extracts
from infected and transfected cells. Mobility shift assays were per-
formed in nuclear extracts from infected (4 h p.i.) S. frugiperda cells
[lanes 4 (Sf)], from infected TN-368 cells [lanes 4 (TN-368)], and from
TN-368 cells transfected with either pIE1 (lanes IE1) or pHindG (lanes
G) with oligonucleotide IRprox as probe and poly(dA-dT) as nonspecific
competitor. The polyclonal anti-IE1 and anti-IE2 sera and the preim-
mune serum were used for supershift experiments. Lanes 2, no sera
were added. The position of the tripartite complex and of the complex
formed in transfected cells are marked by a filled and open arrowhead,
respectively. The lanes are numbered.
FIG. 9. The tripartite complex is based on protein–protein interac-
tions with one binding peptide. Mobility shift assays were performed in
nuclear extracts from infected (4 h p.i.) S. frugiperda cells with oligo-
nucleotide IRprox as probe and poly(dA-dT) as nonspecific competitor
[lanes 4 (AT)]. Protein–DNA complexes were treated with 0.0001,
0.0005, and 0.001 U of chymotrypsin or with 0.5, 1, 5, 10, and 20 mg of
dispase. The detergent DOC was added to a final concentration of 0.05,
0.1, 0.2, and 0.3%. In addition to 0.2% DOC, NP-40 was added to a final
concentration of 1% as control.
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nuclear extracts from infected cells may correlate with
the formation of the tripartite complex. If IE1 and IE0
interact with sequences of the inverted repeat only as
homo- and heterodimers, binding may result in three
differently shifted complexes.
We next prepared nuclear extracts at different times
p.i., which were tested for the presence of IE1 and IE0
(Fig. 10b). The same extracts were used for mobility shift
assays to analyze whether the varying ratios of IE1 and
IE0 in the course of infection result in a different com-
position of the tripartite complex. Our results indeed
indicate a change in the intensity of each of the three
parts of the complex (Fig. 10a). The two more slowly
migrating bands were the strongest with extracts pre-
pared at 4 or 6 h p.i., whereas the fastest migrating band
became more intense with extracts prepared at 12, 24, or
48 h p.i. and correlated with the disappearance of the
slowest migrating band (Fig. 10a). Alterations of the tri-
partite complex may result from the decreasing IE0 ex-
pression during infection.
Sequences involved in complex formation with
extracts from cells expressing IE1 and IE0
Our results from mobility shift assays indicate that
sequences of the proximal inverted repeat are able to
interact with factors, presumably IE1 and IE0 in infected
and in transfected cells. Furthermore, binding appears to
occur with different affinity at the two half-sites of the
repeat. We performed phenanthroline-copper footprint-
ing of the complex preformed either in extracts from
infected cells or from cells expressing only IE1 to identify
the sequences that were involved in protein binding.
Initially, mobility shift assays were performed with a
promoter fragment of 298 bp as the probe that corre-
sponds to the promoter sequences in construct pHE65-
CAT220P (see Fig. 1b). The complexes formed with ex-
tracts either from TN-368 cells prepared at 4 h p.i. or from
TN-368 cells transfected with pHindG were resolved by
electrophoresis on 5% polyacrylamide gels followed by
the chemical cleavage of the unprotected sequences.
The resulting sequences were analyzed on 6% sequenc-
ing gels (Fig. 11). Our results indicate that the complete
inverted repeat in addition to the upstream and down-
stream flanking sequences are protected by factors
present both in infected and in transfected cells (Fig. 11).
It is worth mentioning that the protected sequences are
only observed with the noncoding strand, whereas no
significant protection is visible with the coding strand.
Protection of nucleotides 2153 to 2123 relative to the
transcriptional start site was stronger than the protection
of the nucleotides 2123 to 2109 (Fig. 11). This finding
indicates differences in the binding affinity of either half-
site of the inverted repeat.
DISCUSSION
By studying the regulation of the he65 promoter in
transient expression assays, we have demonstrated that
IE1 is sufficient for promoter activation in the presence of
hr4a. Furthermore, our results indicate the putative in-
volvement of IE0 in the regulation of the he65 gene
during the infection cycle. Since IE1 activation depends
on the presence of at least the proximal inverted repeat
of hr4a, we have performed studies on DNA–protein
interactions. Our results of DNaseI assays have shown
FIG. 10. Time course of IE1 and IE0 expression and the formation of the tripartite complex. (a) Shift assays were performed with oligonucleotide
IRprox as probe in extracts from uninfected S. frugiperda cells with poly(dG-dC) as nonspecific competitor (lanes GC). Poly(dA-dT) (lanes AT) was used
for shift assays in extracts from S. frugiperda cells prepared at 4, 6, 12, 24, and 48 h p.i. (lanes 4, 6, 12, 24, and 48). (b) The same extracts used for
the shift experiments were analyzed by immunoblotting with the polyclonal serum anti-IE1. Protein size markers are indicated on the left. (c) Crude
nuclear extracts were prepared from uninfected TN-368 cells (lane un), from cells at 4 h p.i. (lane 4), or from cells transfected with either pIE1 (lane
IE1) or pHindG (lane G). Protein size markers are indicated on the right. The position of IE1 and IE0, respectively, are indicated by arrowheads.
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FIG. 11. Phenanthroline-copper footprinting of the complex formed in extracts from infected or transfected TN-368 cells. The 39-end labeled
HindIII/StyI fragment of pHE65-CAT220P was incubated with extracts from TN-368 cells prepared at 4 h p.i. or with extracts from cells transfected with
pHindG. The formed complex (lanes bound) and the free probe (lanes free) were digested and resolved on a 6% sequencing gel. A sequencing ladder
(lanes G, C, T, and A) is shown; DNA fragment sizes are depicted on the left. Strong protection is indicated by a filled bar and weak protection is
indicated by a hatched bar. The protected sequences close to and at the proximal inverted repeat are shown underneath the autoradiogram. The
numbers on the right and on top of the sequences refer to the nucleotides relative to the he65 transcriptional start.
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that host factors present in S. frugiperda cells can inter-
act with the flanking sequences of the two inverted
repeats of hr4a. Specific interactions with factors present
only in nuclear extracts from infected cells were detect-
able at the left half-site of the proximal inverted repeat.
The potential of these sequences to form complexes in
infected cells was further investigated by mobility shift
assays, indicating that IE1 is part of the DNA binding
complex in extracts from infected S. frugiperda and TN-
368 cells. The specific binding complex migrates as a
tripartite complex that may reflect binding of oligomers
with a single binding peptide as indicated by protein
clipping bandshifts and treatment with DOC, respec-
tively. The possible candidates are IE1 and IE0 because
both contain the same DNA binding domain (Kovacs et
al., 1991, 1992; Rodems et al., 1997). Our evidence for the
involvement of IE0 in the binding complex is based on
the observation that the changing ratios of IE1 and IE0
during infection correlate with changes of the tripartite
complex. When almost no IE0 was present in extracts
from infected cells, the faster migrating band of the
tripartite complex comigrated with the complex observed
with extracts from cells transfected with IE1-expressing
plasmids.
To identify the minimal sequences that are required for
complex formation, we tested half-sites of the proximal
inverted repeat with varying lengths of the flanking se-
quences for binding. Our results indicate that the left
half-site of the repeat in addition to at least 9 bp of the
flanking sequences are sufficient to form the tripartite
binding complex. The right half-site of the repeat shows
weak binding affinity which is in line with the finding that
sequences immediately downstream of the inverted re-
peat differ from the upstream flanking sequences.
Previous studies also suggest the interaction of IE1
with sequences of the hrs. Mobility shift assays initially
indicate that proteins of whole-cell extracts prepared
from S. frugiperda cells transfected with IE1-expressing
plasmids interact with oligonucleotides containing one
half-site of a palindrome within hr5 (Guarino and Dong,
1991, 1994). Evidence for the presence of IE1 in the
DNA–protein binding complex emerges from supershift
experiments with antibodies against IE1 (Choi and
Guarino, 1995a), and deletion studies of the IE1 gene
indicating that the C terminus is required for the binding
activity (Kovacs et al., 1992). The direct interaction has
been shown for in vitro synthesized IE1 (Choi and
Guarino, 1995b; Rodems and Friesen, 1995), which is
able to interact as a dimeric complex with both half-sites
of the palindrome (Rodems and Friesen, 1995). Recently,
the existence of a specific IE1 binding motif has been
postulated that is located within the palindromic se-
quences of hrs (Leisy et al., 1997). All previous studies
have concentrated on the inverted repeat although the
oligonucleotides used as probes in mobility shift assays
have included the flanking sequences (Fig. 12). Our re-
sults are consistent with the observations on the inverted
repeat as a potential binding site, but in addition, our
studies reveal the important role of the flanking se-
quences in the complex formation. The different binding
affinities of both half-sites of the proximal repeat in hr4a
further support our conclusion that both the inverted
repeat and the flanking sequences are involved in DNA–
protein interactions. As depicted in Fig. 12, there are
extensive homologies of sequences in the repeat and
the flanking regions with sequences including the pe38
transcriptional start site. Leisy et al. (1997) provide evi-
dence that the 8-bp element immediately upstream of the
transcriptional start site is involved in the negative reg-
ulation of the pe38 promoter by IE1. We have used an
oligonucleotide with all conserved nucleotides as effi-
cient competitor in mobility shift assays (data not
shown), confirming the involvement of IE1 in the complex
that is formed either at the pe38 promoter and the in-
verted repeat in hr4a. Furthermore our results of phenan-
throline-copper footprinting and mobility shift assays pre-
dict that the conserved sequences upstream of the left
half-site of the repeat are essential for the binding com-
plex (Fig. 12).
IE1 can bind as a dimer to the inverted repeat (Ro-
dems and Friesen, 1995), alternatively one might envi-
sion a higher order complex that consists of a homo- or
heterodimer formed by IE1 and IE0 at the left half-site
and the flanking region. Cooperativity would lead to the
binding at the right half-site that might trigger the inter-
action with host factors. The recent finding of multiple
IE1 domains involved in DNA binding supports this no-
tion (Rodems et al., 1997).
Deletion studies of the he65 promoter indicate that
both half-sites in addition to the upstream flanking region
are essential for IE1 activation, which is in line with
previous studies (Guarino and Dong, 1994; Rodems and
Friesen, 1993). The minimal he65 promoter containing
the proximal inverted repeat is less active than the pro-
moter construct with the complete hr4a when viral fac-
tors in addition to IE1 are present. Thus the complete
hr4a seems to be involved in he65 regulation during
infection. Our results then suggest that both IE1 and IE0
play a role in the regulation of the he65 promoter al-
though the exact mode of regulation remains to be de-
fined.
MATERIALS AND METHODS
Cells and virus
Trichoplusia ni TN-368 (Hink, 1970) and Spodoptera
frugiperda IPLB21 cells (Vaughn et al., 1977) were grown
as previously described (Knebel-Mo¨rsdorf et al., 1993).
Infection with the AcMNPV plaque isolate E (Tjia et al.,
1979) was performed at a multiplicity of infection of 10
PFU/cell. Time zero was defined as the time when the
inoculum was added to the cells. Cells were grown in
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suspension, and then prior to infection or transfection,
they were plated into monolayer cultures.
Plasmid constructions and oligonucleotides
The plasmids pEcoQ (Becker and Knebel-Mo¨rsdorf,
1993), pIE1, pHE65-CAT220, and pHE65-CAT184 were
described earlier (Murges et al., 1997). The duplicated
29-bp oligonucleotide, 59AGCTTTGCAGGTCGACTCTA-
GAGGATCCAGATC39/39AACGTCCAGCTGAGATCTCC
TAGGTCTAGTCGA59 was inserted into the HindIII site of
pHE65-CAT220 to construct pHE65-CAT220P. The in-
serted oligonucleotide in this plasmid is located up-
stream of the he65 promoter sequences and carries SalI,
XbaI, and BamHI sites. The plasmid pAcHindA1-HK con-
tains a 4-kb HindIII-KpnI fragment isolated from the
cloned fragment HindIIIA1 of AcMNPV DNA (Becker and
Knebel-Mo¨rsdorf, unpublished results). The plasmid
pHE65-CAT474 was generated by isolating the fragment
StyI (blunt-ended)-XhoII of plasmid pAcHindA1-HK and
inserting it into the BamHI and blunt-ended XhoI sites of
pBLCAT3 (Luckow and Schu¨tz, 1987). The resulting con-
struct pHE65-CAT474 contains the entire hr4a region
(Guarino et al., 1986a) in addition to the he65 promoter
sequences. Plasmids containing various lengths of hr4a
sequences at the 59 end of the he65 promoter se-
quences were all constructed by inserting the corre-
sponding oligonucleotides (Fig. 1b) into pHE65-CAT184.
All oligonucleotides were synthesized on an Applied
Biosystems 394 DNA/RNA synthesizer. After heating at
95°C for 5 min, complementary pairs were annealed for
25 min each at 65 and 37°C and ligated into pHE65-
CAT184. Each of the plasmids pHE65CAT-IRprox,
pHE65CAT-IRS, and pHE65CAT-IR carries the oligonucle-
otides within the ClaI site located in the he65 promoter
and the PstI site. The oligonucleotides IRL-UF8, IRR-DF,
and IRL-UF8s were inserted into the ClaI and blunt-
ended SalI sites generating plasmids pHE65CAT-IRL/
UF8, pHE65CAT-IRR/DF, and pHE65CAT-IRL/UF8s (see
Fig. 1b).
Transfection experiments
S. frugiperda (3–4 3 105) or TN-368 cells in 60-mm
dishes were transfected by calcium phosphate precipi-
tation with 10 mg of a promoter-CAT gene construct (see
Fig. 1b) and with either 5 mg of the IE1-expressing plas-
mid or pBluescipt (Stratagene) as negative control. Cells
were infected with AcMNPV (10 PFU/cell) at 4 h prior to
transfection. Alternatively, liposome-mediated transfec-
tion (Felgner et al., 1987) of TN-368 cells was performed.
The liposome-solution was prepared by mixing dimeth-
yldioctadecylammonium bromide (Sigma) and L-phos-
phatidylethanolamine diolecyl (Sigma) in a 0.5:1 molar
ratio dissolved in 100% ethanol (Campbell, 1995). After a
1:20 dilution in H2O, 30 ml of liposome solution was
FIG. 12. Potential nucleotides close to and at inverted repeats that interact with IE1 and IE0. (a) The nucleotide sequence of the proximal inverted
repeat of hr4a. The 24-bp repeat is boxed. The numbers refer to the nucleotides relative to the transcriptional start site of the he65 promoter. The filled
and hatched bar indicates the protected sequences observed by phenanthroline-copper footprinting. The shaded sequences indicate interaction with
host factors as shown by DNaseI footprinting analyses. The asterisks above and underneath the sequences depicts the conserved nucleotides to
the pe38 promoter sequences. The 8-bp element predicted as IE1 binding motif by Leisy et al. (1997) is shown by a broken line. (b) Nucleotide
sequence of the leftmost palindrome of hr5 used as probe in mobility shift assays by Rodems and Friesen (1995). The homologous nucleotides to
pe38 located at the upstream flanking region are underlined. (c) Sequences of the pe38 promoter and the consensus sequence from the hr
palindromes with the boxed 8-bp element as suggested by Leisy et al. (1997). The asterisks indicate the conserved nucleotides. The arrow shows
the transcriptional start site of the pe38 promoter.
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added to 1.5 mg of plasmid DNA, which was used for
transfection of 2 3 105 cells in 35-mm dishes. For both
transfection procedures, the ratio of the reporter and the
IE1-expressing plasmids was 2:1. Cells were harvested
45 h after transfection, and cell extracts were tested for
CAT activity as described (Krappa et al., 1992).
Production of polyclonal antibodies
The production of polyclonal antisera directed against
PE38 and IE2 was described previously (Krappa et al.,
1995). The polyclonal anti-IE1 serum is directed against
the N terminus of the ie1 gene, which was overex-
pressed as a fusion protein with mouse dihydrofolate
reductase (DHFR). The fragment BamHI/StuI of the cDNA
clone ie1 (Krappa and Knebel-Mo¨rsdorf, 1991), which
includes 31 bp of the 59 untranslated region and 124 aa
of the N terminus of the ie1 gene, was inserted into the
BglII and SmaI sites of the pQE-40 vector (Qiagen). The
resulting plasmid pQE-IE1(0.5) carries the histidine-
tagged IE1-DHFR fusion gene, which was overexpressed
in Escherichia coli M15/pREP4 by induction with isopro-
pyl-b-D-thiogalactopyranoside and purified under dena-
turing conditions. Polyclonal antiserum was produced by
immunizing rabbits with denatured IE1-DHFR by stan-
dard procedures (Harlow and Lane, 1988).
Immunoblotting
Proteins were resolved by SDS–10% polyacrylamide
gel electrophoresis (Laemmli, 1970) and processed as
described earlier (Krappa et al., 1995). Briefly, the poly-
clonal anti-IE1 serum was used at a dilution of 1:10,000
or 1:20,000, incubated with the secondary, horseradish
peroxidase-conjugated antibodies, and the antigen-anti-
body complexes were revealed by enhanced chemilumi-
nescence (ECL system, Amersham).
Preparation of nuclear extracts
Nuclear extracts were prepared from uninfected cells
and from cells at different times p.i. with AcMNPV as
described earlier (Krappa et al., 1992). Accordingly, nu-
clear extracts from TN-368 cells were prepared at 48 h
after transfection with 0.5–1 mg of IE1-expressing plas-
mid per 1 3 108 cells.
DNaseI footprinting
The conditions for the DNA-binding reactions, the
DNaseI cleavage, and the extraction and analysis of the
cleavage products were as described earlier (Krappa et
al., 1992).
Gel mobility shift assays and competition studies
The preparation of radiolabeled oligonucleotides and
the DNA–protein binding conditions were previously de-
scribed (Krappa et al. 1992). About 100 ng of the labeled
oligonucleotide was incubated with 2 mg of nuclear ex-
tract at room temperature for 20 min in the presence of
1 mg of poly(dA-dT), poly(dI-dC), or poly (dG-dC). The
DNA–protein complexes were resolved at room temper-
ature on 4 or 5% polyacrylamide gels in 45 mM Tris/HCl,
45 mM sodium borate, 1 mM EDTA (0.53 TBE) by elec-
trophoresis at 250 V for 2 h. For competition experiments,
usually 100 ng of unlabeled, double-stranded oligonucle-
otide was added to the DNA–protein binding reaction
mixtures prior to addition of the labeled nucleotide
probe. The reaction mixtures were allowed to preincu-
bate at room temperature for 5 min.
Supershift analysis, DOC and protein clipping
bandshift assays
Polyclonal antisera were added to the preformed
DNA–protein complexes, and incubation was continued
at room temperature for 10 min. The shifted complexes
were analyzed by electrophoresis on 5% PAA gels.
DOC was added to the reaction mixture at the con-
centrations indicated (see Fig. 9) 8 min after the labeled
nucleotide probe, and the mixtures were incubated at
room temperature for additional 10 min (Baeuerle and
Baltimore, 1988). As a control, NP-40 was added to a final
concentration of 1% to reverse the function of DOC as
detergent.
Protein clipping bandshift assays (Schreiber et al.,
1988) were performed by adding the proteases chymo-
trypsin or dispase to the DNA–protein complexes at the
concentrations indicated (see Fig. 9). The DNA–protein
complexes were preformed for 10 min followed by the
addition of the proteases and incubation at room tem-
perature for 5 min.
Phenanthroline-copper footprinting analysis
The HindIII/StyI fragment of pHE65-CAT220P, including
the hr4a/he65 promoter sequences, was 39-end labeled
at the HindIII restriction site by fill-in reaction with Kle-
now polymerase and after purification used as DNA
probe. Published procedures (Papavassiliou and Silver-
stein, 1990) were adapted as follows. Binding reactions
were scaled up 15-fold as compared to the mobility shift
assays and fractionated by polyacrylamide gel electro-
phoresis as described above. In situ digestion of the
DNA by the nuclease activity of 1,10-phenanthroline-cu-
prous complex was allowed to proceed for 15–20 min at
18°C. DNAs from free and bound fractions were visual-
ized by autoradiography of the wet gel for 2 h at 4°C,
then the radioactive bands were eluted from the corre-
sponding areas of the gel in 500 ml elution buffer (0.5 M
CH3COONH4, pH 7.5, 1 mM EDTA, 0.1% SDS) overnight at
37°C. The DNA was extracted with phenol/chloroform/
isoamyl alcohol to which 5 mg of glycogen (Boehringer
Mannheim) per sample was added. Equal Cerenkov
counts of the bound and free DNA fractions, respectively,
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were loaded immediately on a 6% polyacrylamide, 7 M
urea sequencing gel and electrophoresed in 0.53 TBE
buffer at constant power (40 W) for 45–60 min. Following
electrophoresis, the gel was transferred to Whatmann
3MM paper, vacuum-dried, and exposed to Kodak XAR-5
or BIOMAX films with an intensifying screen for 1–3 days
at room temperature or at 270°C.
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